
On the Cover
NIH scientists have used RNA interference (RNAi) technology to identify dozens of genes which may represent new therapeutic targets for treating Parkinson’s disease. The scientists used RNAi to find genes that interact with parkin (green), a protein that tags damaged mitochondria (red).
NIH/NCATS